[go: up one dir, main page]

WO2008130053A1 - プロテインｇとアビジン類との融合タンパク質 - Google Patents

プロテインｇとアビジン類との融合タンパク質 Download PDF

Info

Publication number
WO2008130053A1
WO2008130053A1 PCT/JP2008/057866 JP2008057866W WO2008130053A1 WO 2008130053 A1 WO2008130053 A1 WO 2008130053A1 JP 2008057866 W JP2008057866 W JP 2008057866W WO 2008130053 A1 WO2008130053 A1 WO 2008130053A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
avidin
fused
antibody
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057866
Other languages
English (en)
French (fr)
Inventor
Yuichiro Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYNTHERA TECHNOLOGIES Co Ltd
Original Assignee
SYNTHERA TECHNOLOGIES Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYNTHERA TECHNOLOGIES Co Ltd filed Critical SYNTHERA TECHNOLOGIES Co Ltd
Priority to JP2009510871A priority Critical patent/JP5211041B2/ja
Publication of WO2008130053A1 publication Critical patent/WO2008130053A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

【課題】標的抗原の検出法に用いる標識化抗体（抗体に標識物質を固定した抗体）を作製するにあたり、カップリング法等の化学結合法を用いる必要がなく、かつ非特異結合を十分に抑制することが可能な、アンカー物質を提供する。 【解決手段】本発明の融合タンパク質は、プロテインＧ又はその一部からなるタンパク質と、アビジン類又はその一部からなるタンパク質とを含む融合タンパク質である。本発明の標識化抗体は、IgG抗体、本発明の融合タンパク質、及びビオチン化標識物質を含んでなるものである。
PCT/JP2008/057866 2007-04-23 2008-04-23 プロテインｇとアビジン類との融合タンパク質 Ceased WO2008130053A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009510871A JP5211041B2 (ja) 2007-04-23 2008-04-23 プロテインｇとアビジン類との融合タンパク質

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007112779 2007-04-23
JP2007-112779 2007-04-23

Publications (1)

Publication Number Publication Date
WO2008130053A1 true WO2008130053A1 (ja) 2008-10-30

Family

ID=39875572

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057866 Ceased WO2008130053A1 (ja) 2007-04-23 2008-04-23 プロテインｇとアビジン類との融合タンパク質

Country Status (2)

Country Link
JP (1) JP5211041B2 (ja)
WO (1) WO2008130053A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5647599B2 (ja) * 2009-03-02 2015-01-07 日本たばこ産業株式会社 生物学的試料中の物質を検出する方法
CN115819620A (zh) * 2022-09-24 2023-03-21 上海英基生物科技有限公司 可用于抗体定点偶联的融合蛋白及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503032A (ja) * 1986-03-21 1988-11-10 フアーマシア・アー・ベー 免疫グロブリン結合性タンパク質の産生方法と手段
JP2003517293A (ja) * 1999-07-20 2003-05-27 セプティア， インコーポレイテッド Ｄｓｐ−１１二重特異性ｍａｐキナーゼホスファターゼ
WO2006043675A1 (ja) * 2004-10-22 2006-04-27 Cellfree Sciences Co., Ltd. 無細胞タンパク質合成用細胞抽出液及び該抽出液の調製方法。
WO2006049289A1 (ja) * 2004-11-01 2006-05-11 Tokyo Metropolitan Organization For Medical Research 標的物質の検出方法
JP2006132980A (ja) * 2004-11-02 2006-05-25 Toyobo Co Ltd タンパク質の固定化方法
WO2006062200A1 (ja) * 2004-12-09 2006-06-15 Universal Bio Research Co., Ltd. 核酸ライブラリー及びタンパク質ライブラリー

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63503032A (ja) * 1986-03-21 1988-11-10 フアーマシア・アー・ベー 免疫グロブリン結合性タンパク質の産生方法と手段
JPH08205875A (ja) * 1986-03-21 1996-08-13 Pharmacia Ab 免疫グロブリン結合性タンパク質の産生方法
JP2003517293A (ja) * 1999-07-20 2003-05-27 セプティア， インコーポレイテッド Ｄｓｐ−１１二重特異性ｍａｐキナーゼホスファターゼ
WO2006043675A1 (ja) * 2004-10-22 2006-04-27 Cellfree Sciences Co., Ltd. 無細胞タンパク質合成用細胞抽出液及び該抽出液の調製方法。
WO2006049289A1 (ja) * 2004-11-01 2006-05-11 Tokyo Metropolitan Organization For Medical Research 標的物質の検出方法
JP2006132980A (ja) * 2004-11-02 2006-05-25 Toyobo Co Ltd タンパク質の固定化方法
WO2006062200A1 (ja) * 2004-12-09 2006-06-15 Universal Bio Research Co., Ltd. 核酸ライブラリー及びタンパク質ライブラリー

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AKERSTROM B. ET AL.: "Definition of IgG- and Albumin-binding Regions of Streptococcal Protein G", J. BIOL. CHEM., vol. 262, 1987, pages 13388 - 13391, XP002969227 *
FREITAG S. ET AL.: "Structural studies of the streptavidin binding loop", PROTEIN SCIENCE, vol. 6, 1997, pages 1157 - 1166, XP002325362 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5647599B2 (ja) * 2009-03-02 2015-01-07 日本たばこ産業株式会社 生物学的試料中の物質を検出する方法
CN115819620A (zh) * 2022-09-24 2023-03-21 上海英基生物科技有限公司 可用于抗体定点偶联的融合蛋白及其应用

Also Published As

Publication number Publication date
JP5211041B2 (ja) 2013-06-12
JPWO2008130053A1 (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
WO2010019414A3 (en) Detecting nucleic acid
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2009053928A3 (en) Cartridge for a biological sample
WO2008060394A3 (en) Methods and assays for detecting gp73-specific autoantibodies
WO2009048530A3 (en) Highly multiplexed particle-based assays
WO2008082984A3 (en) Non-denaturing lysis reagent for use with capture-in-solution immunoassay
EP2224017A4 (en) PROCESS FOR INCREASING THE NUCLEIC ACID TARGET SEQUENCE AND PROBE USED THEREFOR
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
BRPI0818877A2 (pt) Método e sistema para análise semi-quantitativa ou quantitativa de ensaios
WO2012038820A3 (en) Immunochromatography devices, methods and kits
WO2011056606A8 (en) Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
WO2011100749A3 (en) Methods and materials for detecting viral or microbial infections
WO2008098115A3 (en) Optimized igf-1r antibodies and methods of using the same
WO2010096674A3 (en) A+ biomarker assays
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
WO2008095905A3 (en) Pathogen binding
WO2011053565A3 (en) Compositions and methods for detecting a tauopathy
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
WO2005095461A3 (en) Gold-binding protein and use thereof
EP2105447A4 (en) ANTIBODIES OF AVIAN ORIGIN CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB1, METHOD OF IMMUNOLOGICAL DETERMINATION FOR HUMAN HMGB1, AND IMMUNOLOGICAL DETERMINATION REAGENT FOR HUMAN HMGB1
IL207573A (en) Methods for Isolating and Identifying At least One Nucleotide Sequence Encoded for Antibody or Ligand-Binding Antibody Selected
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2007087521A3 (en) Cd86 and cd80 receptor competition assays
WO2009120183A3 (en) System for the detection of a biological pathogen and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08751995

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009510871

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08751995

Country of ref document: EP

Kind code of ref document: A1